Optimizing sampling device for the fecal immunochemical test increases colonoscopy yields in colorectal cancer screening

European Journal of Cancer Prevention

Volumn 25, Issue 2, 2016, Pages 115-122

  Huang, Yanqin ^a   Li, Qilong ^b   Ge, Weiting ^a   Hu, Yue ^a   Cai, Shanrong ^a   Yuan, Ying ^a   Zhang, Suzhan ^a   Zheng, Shu ^a  

^a China National Ministry of Education   (China)

^b Jiashan Institute of Oncology Prevention and Treatment   (China)

Author keywords

cancer screening; colorectal cancer; fecal immunochemical test; sampling bias

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CHINA; COLONOSCOPY; COLORECTAL CANCER; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOASSAY ANALYZER; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OC SENSOR AUTOMATED FECAL BLOOD ANALYZER; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; ADENOMA; CANCER STAGING; COLORECTAL NEOPLASMS; DEVICES; DIAGNOSTIC KIT; EARLY CANCER DIAGNOSIS; ENZYME IMMUNOASSAY; FOLLOW UP; MIDDLE AGED; OCCULT BLOOD; PROCEDURES; PROGNOSIS; SPECIMEN HANDLING; STANDARDS; TIME FACTOR;

DIAGNOSTIC KIT; HEMOGLOBIN;

ADENOMA; ADULT; AGED; CHINA; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; OCCULT BLOOD; PROGNOSIS; REAGENT KITS, DIAGNOSTIC; SPECIMEN HANDLING; TIME FACTORS;

EID: 84974559708     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000154     Document Type: Article

References (20)

1. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. (2007). Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 99:1462-1470.
2. Allison JE, Fraser CG, Halloran SP, Young GP (2014). Population screening for colorectal cancer means getting FIT: the past, present, and future of colo-rectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver 8:117-130.
3. Halloran SP, Launoy G, Zappa M (2012). European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition-faecal occult blood testing. Endoscopy 44 (Suppl 3):SE65-SE87.
4. Huang Y, Ge W, London V, Li Q, Cai S, Zhang S, Zheng S (2013). Diagnostic inconsistency of faecal immunochemical tests for haemoglobin in population screening of colorectal cancer. Clin Chem Lab Med 51:2173-2180.
5. Huang Y, Li Q, Ge W, Cai S, Zhang S, Zheng S (2014). Predictive power of quantitative and qualitative fecal immunochemical tests for hemoglobin in population screening for colorectal neoplasm. Eur J Cancer Prev 23:27-34.
6. Hundt S, Haug U, Brenner H (2009). Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma. Ann Intern Med 150:162-169.
7. Jorgensen OD, Kronborg O, Fenger C (2002). A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50:29-32.
8. Lee JK, Liles EG, Bent S, Levin TR, Corley DA (2014). Accuracy of fecal immu-nochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 160:171-181.
9. Levi Z, Hazazi R, Rozen P, Vilkin A, Waked A, Niv Y (2006). A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test. Aliment Pharmacol Ther 23:1359-1364.
10. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, et al. (2007). A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 146:244-255.
11. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58:130-160.
12. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328:1365-1371.
13. Mandy PS, Alana CS, Gwinnett C, Melissa TA, Mitchell AB, Randy LM, Centers for Disease Control and Prevention (CDC) (2011). Vital signs: Colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep 60:884-889.
14. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y (2005). A comparison of the immunochemical fecal occult blood test and total colo-noscopy in the asymptomatic population. Gastroenterology 129:422-428.
15. Park DI, Ryu S, Kim YH, Lee SH, Lee CK, Eun CS, Han DS (2010). Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 105:2017-2025.
16. Parra-Blanco A, Gimeno-Garcia AZ, Quintero E, Nicolas D, Moreno SG, Jimenez A, et al. (2010). Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 45:703-712.
17. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, et al. (2012). Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366:697-706.
18. Rabeneck L, Rumble RB, Thompson F, Mills M, Oleschuk C, Whibley A, et al. (2012). Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol 26:131-147.
19. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD (2002). Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 50:840-844.
20. Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, Niv Y (2005). Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 100:2519-2525.